338 related articles for article (PubMed ID: 33050663)
1. Drug-Eluting Stents and Balloons-Materials, Structure Designs, and Coating Techniques: A Review.
Rykowska I; Nowak I; Nowak R
Molecules; 2020 Oct; 25(20):. PubMed ID: 33050663
[TBL] [Abstract][Full Text] [Related]
2. The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease.
Costopoulos C; Latib A; Naganuma T; Sticchi A; Figini F; Basavarajaiah S; Carlino M; Chieffo A; Montorfano M; Naim C; Kawaguchi M; Giannini F; Colombo A
JACC Cardiovasc Interv; 2013 Nov; 6(11):1153-9. PubMed ID: 24262615
[TBL] [Abstract][Full Text] [Related]
3. Comparison among drug-eluting balloon, drug-eluting stent, and plain balloon angioplasty for the treatment of in-stent restenosis: a network meta-analysis of 11 randomized, controlled trials.
Lee JM; Park J; Kang J; Jeon KH; Jung JH; Lee SE; Han JK; Kim HL; Yang HM; Park KW; Kang HJ; Koo BK; Kim HS
JACC Cardiovasc Interv; 2015 Mar; 8(3):382-394. PubMed ID: 25703886
[TBL] [Abstract][Full Text] [Related]
4. Treatment of drug-eluting stent restenosis: Comparison between drug-eluting balloon versus second-generation drug-eluting stents from a retrospective observational study.
Basavarajaiah S; Naganuma T; Latib A; Sticchi A; Ciconte G; Panoulas V; Chieffo A; Montorfano M; Carlino M; Colombo A
Catheter Cardiovasc Interv; 2016 Oct; 88(4):522-528. PubMed ID: 26715370
[TBL] [Abstract][Full Text] [Related]
5. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents.
Alfonso F; Pérez-Vizcayno MJ; Cuesta J; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Cequier A; Velázquez M; Moreno R; Mainar V; Domínguez A; Moris C; Molina E; Rivero F; Jiménez-Quevedo P; Gonzalo N; Fernández-Pérez C;
JACC Cardiovasc Interv; 2018 May; 11(10):981-991. PubMed ID: 29798776
[TBL] [Abstract][Full Text] [Related]
6. In-stent restenosis: the gold standard has changed.
Chin K
EuroIntervention; 2011 May; 7 Suppl K():K43-6. PubMed ID: 22027726
[TBL] [Abstract][Full Text] [Related]
7. Intravascular imaging analysis of a drug-eluting balloon followed by a bare metal stent compared to a drug-eluting stent for treatment of de novo lesions.
Choi W; Chae IH; Park JJ; Kim SH; Kang SH; Oh IY; Yoon CH; Cho YS; Youn TJ; Choi DJ
Korean J Intern Med; 2019 Jul; 34(4):819-829. PubMed ID: 29961306
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of drug-eluting balloons for the treatment of in-stent restenosis as compared with drug-eluting stents and with conventional balloon angioplasty.
Oh PC; Suh SY; Kang WC; Lee K; Han SH; Ahn T; Shin EK
Korean J Intern Med; 2016 May; 31(3):501-6. PubMed ID: 26951915
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes following drug-eluting balloons vs. thin-strut drug-eluting stents for treatment of recurrent restenosis in drug-eluting stents.
Wolny R; Kowalik I; Januszek R; Bil J; Figatowski T; Milewski M; Tomasiewicz B; Walczak T; Hrymniak B; Desperak P; Niezgoda P; Chudzik M; Kuźma Ł; Kralisz P; D'Ascenzo F; Hudziak D; Jaguszewski M; Reczuch K; Kubica J; Gil RJ; Dobrzycki S; Bartuś S; Gąsior M; Ochała A; Witkowski A; Wojakowski W; Wańha W
Kardiol Pol; 2022; 80(7-8):765-773. PubMed ID: 35445739
[TBL] [Abstract][Full Text] [Related]
10. Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: a meta-analysis of randomized controlled trials.
Liu L; Liu B; Ren J; Hui G; Qi C; Wang J
BMC Cardiovasc Disord; 2018 Mar; 18(1):46. PubMed ID: 29499651
[TBL] [Abstract][Full Text] [Related]
11. Drug-Eluting Balloons Versus Everolimus-Eluting Stents for In-Stent Restenosis: A Meta-Analysis of Randomized Trials.
Elgendy IY; Mahmoud AN; Elgendy AY; Mojadidi MK; Elbadawi A; Eshtehardi P; Pérez-Vizcayno MJ; Wayangankar SA; Jneid H; David Anderson R; Alfonso F
Cardiovasc Revasc Med; 2019 Jul; 20(7):612-618. PubMed ID: 30126824
[TBL] [Abstract][Full Text] [Related]
12. Evolutionary perspective of drug eluting stents: from thick polymer to polymer free approach.
Hassan S; Ali MN; Ghafoor B
J Cardiothorac Surg; 2022 Apr; 17(1):65. PubMed ID: 35379273
[TBL] [Abstract][Full Text] [Related]
13. Time course of endothelium-dependent and -independent coronary vasomotor response to coronary balloons and stents. Comparison of plain and drug-eluting balloons and stents.
Plass CA; Sabdyusheva-Litschauer I; Bernhart A; Samaha E; Petnehazy O; Szentirmai E; Petrási Z; Lamin V; Pavo N; Nyolczas N; Jakab A; Murlasits Z; Bergler-Klein J; Maurer G; Gyöngyösi M
JACC Cardiovasc Interv; 2012 Jul; 5(7):741-51. PubMed ID: 22814779
[TBL] [Abstract][Full Text] [Related]
14. Comparative Effectiveness of Plain Balloon Angioplasty, Bare Metal Stents, Drug-Coated Balloons, and Drug-Eluting Stents for the Treatment of Infrapopliteal Artery Disease: Systematic Review and Bayesian Network Meta-analysis of Randomized Controlled Trials.
Katsanos K; Kitrou P; Spiliopoulos S; Diamantopoulos A; Karnabatidis D
J Endovasc Ther; 2016 Dec; 23(6):851-863. PubMed ID: 27708143
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Results of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients With Bare-Metal In-Stent Restenosis: 3-Year Follow-Up of the RIBS V Clinical Trial.
Alfonso F; Pérez-Vizcayno MJ; García Del Blanco B; Otaegui I; Masotti M; Zueco J; Veláquez M; Sanchís J; García-Touchard A; Lázaro-García R; Moreu J; Bethencourt A; Cuesta J; Rivero F; Cárdenas A; Gonzalo N; Jiménez-Quevedo P; Fernández C;
JACC Cardiovasc Interv; 2016 Jun; 9(12):1246-1255. PubMed ID: 27339840
[TBL] [Abstract][Full Text] [Related]
16. Acute Thrombogenicity of a Durable Polymer Everolimus-Eluting Stent Relative to Contemporary Drug-Eluting Stents With Biodegradable Polymer Coatings Assessed Ex Vivo in a Swine Shunt Model.
Otsuka F; Cheng Q; Yahagi K; Acampado E; Sheehy A; Yazdani SK; Sakakura K; Euller K; Perkins LEL; Kolodgie FD; Virmani R; Joner M
JACC Cardiovasc Interv; 2015 Aug; 8(9):1248-1260. PubMed ID: 26292590
[TBL] [Abstract][Full Text] [Related]
17. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.
Adriaenssens T; Dens J; Ughi G; Coosemans M; Onsea K; Dubois C; Sinnaeve P; Vrolix M; Desmet W
EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717
[TBL] [Abstract][Full Text] [Related]
18. Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population.
Marquis-Gravel G; Matteau A; Potter BJ; Gobeil F; Noiseux N; Stevens LM; Mansour S
Arq Bras Cardiol; 2017 Oct; 109(4):277-283. PubMed ID: 28977052
[TBL] [Abstract][Full Text] [Related]
19. Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis.
Wang G; Zhao Q; Chen Q; Zhang X; Tian L; Zhang X
Coron Artery Dis; 2019 Nov; 30(7):473-480. PubMed ID: 31464729
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in Stent Technology: Do They Reduce Cardiovascular Events?
Weiss AJ; Lorente-Ros M; Correa A; Barman N; Tamis-Holland JE
Curr Atheroscler Rep; 2022 Sep; 24(9):731-744. PubMed ID: 35821187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
